Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-25

Clinical Trial Update: Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage [NA]

View source ↗

Summary

Clinical trial update indicating termination of a study evaluating simvastatin to prevent vasospasm after aneurysmal subarachnoid hemorrhage, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Aneurysmal Subarachnoid Hemorrhage, Cerebral Vasospasm | NA | Status: TERMINATED | Results posted: 2015-11-25